Compare · CERS vs WDAY
CERS vs WDAY
Side-by-side comparison of Cerus Corporation (CERS) and Workday Inc. (WDAY): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CERS and WDAY operate in EDP Services (Technology), so they compete in similar markets.
- WDAY is the larger of the two at $33.43B, about 56.9x CERS ($587.1M).
- Over the past year, CERS is up 116.2% and WDAY is down 43.2% - CERS leads by 159.3 points.
- WDAY has been more active in the news (16 items in the past 4 weeks vs 3 for CERS).
- WDAY has more recent analyst coverage (25 ratings vs 4 for CERS).
- Company
- Cerus Corporation
- Workday Inc.
- Price
- $2.94+2.08%
- $135.30+5.87%
- Market cap
- $587.1M
- $33.43B
- 1M return
- +11.57%
- +14.65%
- 1Y return
- +116.18%
- -43.15%
- Industry
- EDP Services
- EDP Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 1997
- News (4w)
- 3
- 16
- Recent ratings
- 4
- 25
Cerus Corporation
Cerus Corporation, a biomedical products company, focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion; and INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma, cryoprecipitate reduced. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. Cerus Corporation has collaboration with LifeSouth Community Blood Centers to manufacture INTERCEPT Fibrinogen Complex. The company was incorporated in 1991 and is headquartered in Concord, California.
Workday Inc.
Workday, Inc. provides enterprise cloud applications worldwide. Its applications help its customers to manage critical business functions and optimize their financial and human resources. The company offers a suite of financial management applications, which enable chief financial officers to maintain accounting information in the general ledger; manage financial processes; identify real-time financial, operational, and management insights; enhance financial consolidation; reduce time-to-close; promote internal control and auditability; and achieve consistency across finance operations. It also provides cloud spend management solutions; a suite of human capital management applications that allows organizations to manage the entire employee lifecycle from recruitment to retirement; Workday applications for planning; and applications for analytics and reporting, including augmented analytics to surface insights to the line of business in simple-to-understand stories, machine learning to drive efficiency and automation, and benchmarks to compare performance against other companies. In addition, the company offers Workday applications serving industries, such as healthcare, higher education, and professional services. It serves technology, financial services, business and professional services, healthcare and life sciences, manufacturing, retail, and hospitality industries; and educational institutions, government agencies, and nonprofit organizations. Workday, Inc. has a strategic partnership with Google LLC to digitally transform enterprises worldwide. The company was formerly known as North Tahoe Power Tools, Inc. and changed its name to Workday, Inc. in July 2005. Workday, Inc. was founded in 2005 and is headquartered in Pleasanton, California.
Latest CERS
- Chief Executive Officer Jayaraman Vivek K sold $52,665 worth of shares (16,666 units at $3.16) as part of a pre-agreed trading plan, decreasing direct ownership by 0.74% to 2,232,211 units (SEC Form 4)
- Cerus Corporation to Release Second Quarter 2026 Financial Results on July 30, 2026
- Cerus Corporation filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- Chief Financial Officer Green Kevin Dennis sold $99,105 worth of shares (33,676 units at $2.94) as part of a pre-agreed trading plan and gave a grant of 63,600 shares, decreasing direct ownership by 8% to 1,062,188 units (SEC Form 4) to cover withholding tax
- Chief Operating Officer Jayaraman Vivek K was granted 554,529 shares, gave a grant of 80,000 shares and sold $124,658 worth of shares (42,359 units at $2.94) as part of a pre-agreed trading plan, increasing direct ownership by 24% to 2,248,877 units (SEC Form 4) to satisfy withholding obligation
- Chief Legal Officer Jensen Chrystal gave a grant of 55,000 shares and sold $71,598 worth of shares (24,329 units at $2.94) as part of a pre-agreed trading plan, decreasing direct ownership by 8% to 966,657 units (SEC Form 4) (for withholding tax)
- President and CEO Greenman William Mariner gave a grant of 192,500 shares and sold $299,937 worth of shares (101,919 units at $2.94) as part of a pre-agreed trading plan, decreasing direct ownership by 6% to 5,053,036 units (SEC Form 4) to cover taxes
- Cerus to Showcase New Evidence, Innovation and Global Experience with the INTERCEPT Blood System at the 39th International ISBT Congress
- Director Bjerkholt Eric sold $53,180 worth of shares (20,454 units at $2.60), decreasing direct ownership by 7% to 261,679 units (SEC Form 4)
- Cerus Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Obligation
Latest WDAY
- Workday Adaptive Planning Achieves FedRAMP Moderate Authorization to Support Federal Workforce and Budget Planning
- Workday Learning, Powered by Sana, Now Generally Available as an AI-Native Learning Experience Built on Workday's Trusted Data
- Workday Announces Rising 2026: Where Agentic HR and Agentic Finance Take Center Stage October 12-15 in Las Vegas
- Workday downgraded by Morgan Stanley with a new price target
- CLSA initiated coverage on Workday with a new price target
- Chief Accounting Officer Garfield Mark S. sold $130,530 worth of shares (918 units at $142.19) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 73,718 units (SEC Form 4)
- Large owner Duffield David A converted options into 107,500 shares and sold $14,699,057 worth of shares (107,500 units at $136.74) as part of a pre-agreed trading plan (SEC Form 4)
- SEC Form 144 filed by Workday Inc.
- President, Prod. and Tech. Kazmaier Gerrit S sold $391,785 worth of shares (2,728 units at $143.62) as part of a pre-agreed trading plan and covered exercise/tax liability with 8,976 shares, decreasing direct ownership by 4% to 266,388 units (SEC Form 4) to satisfy tax liability
- Chief Financial Officer Rowe Zane covered exercise/tax liability with 7,953 shares and sold $862,203 worth of shares (6,000 units at $143.70) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 288,460 units (SEC Form 4) to satisfy withholding tax